Model
Edge
EyePoint Pharmaceuticals Inc.
0001736240
Filing type
4
Filing date
Aug 31, 2023
Updated
Sep 1, 2023 ยท 10:51 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership